Dolby Laboratories, Inc. Financials

Market Capitalization $7.69 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	29.90
Forward PE	21.11
Price to Sales TTM	$6.11
Price to Book MRQ	$3.16
Enterprise to Revenue	4.73
Enterprise to EBITDA	18.49

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-09-29
Most Recent Quarter	2024-09-30
Profit Margin	16.87%
Operating Margin	14.15%
Return on Assets TTM	5.16%
Return on Equity TTM	8.92%

Income Statement

Revenue TTM	$1,259,476,992
Revenue per Share TTM	$13.17
Quarterly Revenue Growth	-3.20%
Gross Profit TTM	$1,117,425,024
EBITDA	$358,421,000
Net Income to Common TTM	$212,440,992
Diluted EPS TTM	$2.69
Quarterly Earnings Growth YoY	134.40%

Balance Sheet

Total Cash MRQ	$868,956,992
Total Cash per Share MRQ	$9.11
Total Debt MRQ	$
Total Debt to Equity MRQ	1.97
Current Ratio MRQ	4.14
Book Value per Share MRQ	$25.45

Cash Flow

Operating Cash Flow TTM	$296,096,992
Levered Free Cash Flow TTM	$241,768,496

DLB Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	60,440,700
Float Shares	58,995,388
Avg 10 Volume	494,540
Avg 30 Volume	None
Shares Short	887,729
Short Ratio	3.21
Short % of Shares	1.67%
% Held by Insiders	1.47%
% Held by Institutions	93.98%

Stock Price Summary

Beta	0.98
Fifty Two Week Low	$66.35
Fifty Two Week High	$85.30
Fifty Two Week Change	-6.24%
Day 50 MA	$78.19
Day 200 MA	$77.01

Dividends and Splits

Forward Annual Dividend Rate	$1.32
Forward Annual Dividend Yield	1.66%
Trailing Annual Dividend Rate	$1.23
Trailing Annual Dividend Yield	1.54%
Payout Ratio	44.61%
Dividend Date	2024-12-10
Ex Dividend Date	2024-08-19
Last Split Factor
Last Split Date